← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2022Last known activity
Jan 1, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (13 distinct, 8 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (18)
- NCT07255820Lead sponsorPhase 4Jan 1, 2026
- NCT06856369OfficialPhase 4Jan 22, 2025
- NCT06856369Lead sponsorPhase 4Jan 22, 2025
- NCT06759922Lead sponsorPhase 4Jan 1, 2025
- NCT06759922OfficialPhase 4Jan 1, 2025
- NCT06606886Lead sponsorPhase 4Sep 16, 2024
- NCT06606886OfficialPhase 4Sep 16, 2024
- NCT06602765Lead sponsorN/ASep 5, 2024
- NCT06602765OfficialN/ASep 5, 2024
- NCT06602765Sponsor investigatorN/ASep 5, 2024
- NCT05759442Sponsor investigatorN/AJan 1, 2023
- NCT05817799Lead sponsorPhase 2/Phase 3Jan 1, 2023
- NCT05759442Reponsible party - principal investigatorN/AJan 1, 2023
- NCT05759442Lead sponsorN/AJan 1, 2023
- NCT05817799Reponsible party - principal investigatorPhase 2/Phase 3Jan 1, 2023
Details
- Last known activity
- Jan 1, 2026